Related Experiment Video
Updated: Feb 24, 2026

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
Published on: March 5, 2019
Systemic immune dysregulation in hypertensive disorders of pregnancy persists years after delivery
Maximilian Sabayev1,2, Edward A Ganio1, Ina A Stelzer1,3
1Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Insights
Hypertensive disorders of pregnancy (HDP) are linked to future cardiovascular disease (CVD). Persistent immune system changes in women with HDP history may explain this increased long-term CVD risk.
Area of Science:
- Immunology
- Cardiovascular Health
- Reproductive Medicine
Background:
- Hypertensive disorders of pregnancy (HDP), such as preeclampsia and gestational hypertension, are known risk factors for developing cardiovascular disease (CVD) later in life.
- The precise biological mechanisms connecting HDP to subsequent CVD remain incompletely understood.
Purpose of the Study:
- To investigate the immune cell profiles and functional responses in women with and without a history of HDP across different life stages.
- To identify potential immune signatures associated with HDP that may persist and contribute to long-term CVD risk.
Main Methods:
- Utilized high-dimensional single-cell mass cytometry to analyze maternal immune cell distribution and function.
- Employed multivariable sparse modeling to differentiate HDP cases from normotensive controls at antepartum, postpartum, and midlife timepoints.
Main Results:
- Successfully distinguished HDP cases from controls with high accuracy (AUROC 0.692–0.814) across all study phases.
- Revealed distinct immune signatures unique to each timepoint, indicating dynamic immune dysregulation.
- Identified a persistent immune dysregulation signal in HDP cases, characterized by increased B cell frequency and altered monocyte responses to cytokine stimulation.
Conclusions:
- Persistent immune dysregulation following HDP may be a key factor contributing to the elevated long-term risk of cardiovascular disease development in affected women.
- Understanding these immune alterations offers potential targets for early detection and intervention strategies to mitigate future CVD risk.
Background:
Hypertensive disorders of pregnancy (HDP), including preeclampsia and gestational hypertension, are associated with an increased risk of cardiovascular disease (CVD) later in life. Mechanisms that link HDP to CVD, however, remain unclear.
Methods:
We used a high-dimensional single-cell mass cytometry approach to profile the distribution and functional responses of maternal immune cells in three separate groups of HDP cases and normotensive controls, sampled antepartum, postpartum, and several years postpartum (midlife). We used multivariable sparse modeling to distinguish HDP cases from controls.
Results:
We accurately distinguished HDP cases from controls at all three study timepoints, with area under the receiver operator characteristic (AUROC) curve values of 0.814 for the antepartum group, 0.757 for the postpartum group, and 0.692 for the midlife group. Distinct immune signatures for each model underscore the dynamic dysregulation of the immune system throughout life. In addition, we identified a persistent immune dysregulation signal among HDP cases at all three timepoints, characterized by increased B cell frequency and decreased pSTAT3 response upon cytokine stimulation in classical monocytes.
Conclusions:
Persistent immune dysregulation among women with a history of an HDP may contribute to elevated long-term risk of CVD development.
More Related Videos
Related Concept Videos
Hypertension II: Pathophysiology
Hormonal Regulation
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Heart Failure II: Pathophysiology

